Ja‐Young Han

490 total citations
13 papers, 435 citations indexed

About

Ja‐Young Han is a scholar working on Organic Chemistry, Toxicology and Biomaterials. According to data from OpenAlex, Ja‐Young Han has authored 13 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 3 papers in Toxicology and 2 papers in Biomaterials. Recurrent topics in Ja‐Young Han's work include Synthesis and biological activity (6 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Supramolecular Chemistry and Complexes (3 papers). Ja‐Young Han is often cited by papers focused on Synthesis and biological activity (6 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Supramolecular Chemistry and Complexes (3 papers). Ja‐Young Han collaborates with scholars based in South Korea, United States and United Kingdom. Ja‐Young Han's co-authors include Stuart Cantrill, Diego Benítez, Jishan Wu, Ken Cham‐Fai Leung, Lei Fang, J. Fraser Stoddart, Chung‐Kyu Ryu, Jung Yoon Lee, J. Fraser Stoddart and Su-Kyung Lee and has published in prestigious journals such as Angewandte Chemie International Edition, International Journal of Environmental Research and Public Health and European Journal of Medicinal Chemistry.

In The Last Decade

Ja‐Young Han

12 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ja‐Young Han South Korea	8	367	169	128	101	79	13	435
Zhengtao Li Singapore	12	366 1.0×	187 1.1×	43 0.3×	13 0.1×	43 0.5×	18	452
Swapan Majumdar India	15	427 1.2×	52 0.3×	110 0.9×	21 0.2×	130 1.6×	39	575
Olga A. Mostovaya Russia	13	293 0.8×	148 0.9×	162 1.3×	101 1.0×	157 2.0×	57	472
Hitoshi Okubo Japan	12	391 1.1×	200 1.2×	209 1.6×	39 0.4×	92 1.2×	14	451
P. Šimůnek Czechia	16	472 1.3×	90 0.5×	52 0.4×	16 0.2×	97 1.2×	47	596
Anne Sophie Droz Switzerland	5	277 0.8×	66 0.4×	85 0.7×	25 0.2×	110 1.4×	5	368
Alberto Insuasty Colombia	13	215 0.6×	170 1.0×	34 0.3×	33 0.3×	68 0.9×	30	452
Rocchina Sabia Italy	13	272 0.7×	159 0.9×	146 1.1×	51 0.5×	93 1.2×	16	443
Dalila Belei Romania	14	353 1.0×	79 0.5×	29 0.2×	17 0.2×	185 2.3×	37	475
Janette Houk United States	5	221 0.6×	42 0.2×	39 0.3×	34 0.3×	123 1.6×	6	385

Countries citing papers authored by Ja‐Young Han

Since Specialization

Citations

This map shows the geographic impact of Ja‐Young Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ja‐Young Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ja‐Young Han more than expected).

Fields of papers citing papers by Ja‐Young Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ja‐Young Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ja‐Young Han. The network helps show where Ja‐Young Han may publish in the future.

Co-authorship network of co-authors of Ja‐Young Han

This figure shows the co-authorship network connecting the top 25 collaborators of Ja‐Young Han. A scholar is included among the top collaborators of Ja‐Young Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ja‐Young Han. Ja‐Young Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Kim, Hee‐Ju, et al.. (2024). Effects of Glucagon‐Like Peptide‐1 Receptor Agonist on Bone Mineral Density and Bone Turnover Markers: A Meta‐Analysis. Diabetes/Metabolism Research and Reviews. 40(6). e3843–e3843. 6 indexed citations

Han, Ja‐Young, et al.. (2024). Cardioprotective Effects of PARP Inhibitors: A Re-Analysis of a Meta-Analysis and a Real-Word Data Analysis Using the FAERS Database. Journal of Clinical Medicine. 13(5). 1218–1218. 7 indexed citations

Han, Ja‐Young, et al.. (2024). Prediction of human pharmacokinetic parameters incorporating SMILES information. Archives of Pharmacal Research. 47(12). 914–923.

Han, Ja‐Young, et al.. (2023). Hepatitis Risk in Diabetes Compared to Non-Diabetes and Relevant Factors: A Cross-Sectional Study with National Health and Nutrition Examination Survey (NHANES), 2013–2018. International Journal of Environmental Research and Public Health. 20(6). 4962–4962. 3 indexed citations

Wu, Jishan, Ken Cham‐Fai Leung, Diego Benítez, et al.. (2008). An Acid–Base‐Controllable [c2]Daisy Chain. Angewandte Chemie International Edition. 47(39). 7470–7474. 191 indexed citations

Wu, Jishan, Ken Cham‐Fai Leung, Diego Benítez, et al.. (2008). An Acid–Base‐Controllable [c2]Daisy Chain. Angewandte Chemie. 120(39). 7580–7584. 51 indexed citations

Braunschweig, Adam B., Célia M. Ronconi, Ja‐Young Han, et al.. (2006). Pseudorotaxanes and Rotaxanes Formed by Viologen Derivatives. European Journal of Organic Chemistry. 2006(8). 1857–1866. 50 indexed citations

Ryu, Chung‐Kyu, et al.. (2005). Synthesis and antifungal activity of 5-arylamino-4,7-dioxobenzo[b]thiophenes. Bioorganic & Medicinal Chemistry Letters. 15(10). 2617–2620. 35 indexed citations

Ryu, Chung‐Kyu, et al.. (2005). Synthesis and antifungal activity of 2/3-arylthio- and 2,3-bis(arylthio)-5-hydroxy-/5-methoxy-1,4-naphthoquinones. European Journal of Medicinal Chemistry. 40(5). 438–444. 44 indexed citations

10.

Ryu, Chung‐Kyu, et al.. (2005). Synthesis and Antifungal Activity of 2/3‐Arylthio‐ and 2,3‐Bis(arylthio)‐5‐hydroxy‐/5‐methoxy‐1,4‐naphthoquinones.. ChemInform. 36(45). 1 indexed citations

11.

Hong, Sung‐Yu, et al.. (2004). Synthesis and biological evaluation of benzimidazole-4,7-diones that inhibit vascular smooth muscle cell proliferation. Bioorganic & Medicinal Chemistry Letters. 14(13). 3563–3566. 25 indexed citations

12.

Ryu, Chung‐Kyu, et al.. (2004). Synthesis and antifungal activity of noble 5-arylamino- and 6-arylthio-4,7-dioxobenzoselenazoles. Bioorganic & Medicinal Chemistry Letters. 15(3). 679–682. 19 indexed citations

13.

Ryu, Chung‐Kyu, et al.. (2004). Synthesis and Cytotoxic Activity of 6-(Substituted-Phenyl)Amino-5,8-Quinazolinediones. Medicinal Chemistry Research. 13(5). 249–258. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact